Literature DB >> 1923517

Inhibition of jun transformation by a mutated fos gene: design of an anti-oncogene.

H Okuno1, T Suzuki, T Yoshida, Y Hashimoto, T Curran, H Iba.   

Abstract

The protein products of the fos and jun oncogenes (Fos and Jun) function as transcriptional regulators in the form of homo- or heterodimeric complexes that bind to DNA. Dimerization is mediated by a leucine zipper structure that serves to juxtapose alpha-helical regions of each protein, rich in basic amino acids, that form a bipartite DNA-binding domain. Although Fos participates exclusively in heterodimeric complexes, Jun can function either as a homodimer that has a low apparent affinity for DNA or as a more stable heterodimer with Fos that has a higher apparent affinity for DNA. We have used these properties of Fos and Jun to design a mutated fos gene, lacking a functional DNA-binding domain (supfos1), that suppresses the transforming activity of jun in trans. Here we show that chicken embryo fibroblasts transformed by jun revert to a normal phenotype after infection by a retroviral vector encoding supFos1. Furthermore, infection of normal cells with the supfos1 vector renders them resistant to subsequent transformation by jun. Inhibition of jun transformation was associated with the appearance of supFos1-Jun heterodimers and a reduction in the AP-1 DNA-binding activity contributed by Jun homodimers. These findings demonstrate that the function of leucine zipper-containing transcription factors can be investigated by the procedure of intracellular immunization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923517

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Analysis of fra-2 gene expression.

Authors:  T Yoshida; T Suzuki; H Sato; H Nishina; H Iba
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

3.  AP-1 factors play an important role in transformation induced by the v-rel oncogene.

Authors:  J Kralova; A S Liss; W Bargmann; H R Bose
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Separation of v-Src-induced mitogenesis and morphological transformation by inhibition of AP-1.

Authors:  M C Frame; K Simpson; V J Fincham; D H Crouch
Journal:  Mol Biol Cell       Date:  1994-11       Impact factor: 4.138

5.  Involvement of JunD in transcriptional activation of the orphan receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells.

Authors:  J K Yoon; L F Lau
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Analysis of AP-1 function in cellular transformation pathways.

Authors:  T Suzuki; M Murakami; N Onai; E Fukuda; Y Hashimoto; M H Sonobe; T Kameda; M Ichinose; K Miki; H Iba
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 7.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

8.  Direct transcriptional stimulation of the ornithine decarboxylase gene by Fos in PC12 cells but not in fibroblasts.

Authors:  C Wrighton; M Busslinger
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

9.  Isolation of an allele of reeler by insertional mutagenesis.

Authors:  G G Miao; R J Smeyne; G D'Arcangelo; N G Copeland; N A Jenkins; J I Morgan; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells.

Authors:  Germán A Gil; Daniela F Bussolino; Maximiliano M Portal; Adolfo Alfonso Pecchio; Marianne L Renner; Graciela A Borioli; Mario E Guido; Beatriz L Caputto
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.